Cyber Monday saleUp to 70% OFF
Nuvalent, Inc.Nuvalent, Inc.Nuvalent, Inc.

Nuvalent, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

NUVL chart


Full chart

NUVL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.70 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.48 USD
Net income (FY)
‪−126.22 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪41.45 M‬
Beta (1Y)
1.74

Employees


Employees (FY)
92
Change (1Y)
+30 +48.39%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.37 M‬ USD

About Nuvalent, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
James R. Porter
Website
nuvalent.com
Headquarters
Cambridge
Founded
2017
FIGI
BBG00Z1SLMK5
Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

NUVL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NUVL is 94.67 USD — it has increased by 0.42% in the past 24 hours. Watch Nuvalent, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Nuvalent, Inc. stocks are traded under the ticker NUVL.
NUVL stock has fallen by −1.16% compared to the previous week, the month change is a 6.37% rise, over the last year Nuvalent, Inc. has showed a 43.37% increase.
We've gathered analysts' opinions on Nuvalent, Inc. future price: according to them, NUVL price has a max estimate of 137.00 USD and a min estimate of 100.00 USD. Watch NUVL chart and read a more detailed Nuvalent, Inc. stock forecast: see what analysts think of Nuvalent, Inc. and suggest that you do with its stocks.
NUVL reached its all-time high on Sep 16, 2024 with the price of 113.51 USD, and its all-time low was 7.09 USD and was reached on May 19, 2022. View more price dynamics on NUVL chart.
See other stocks reaching their highest and lowest prices.
NUVL stock is 2.09% volatile and has beta coefficient of 1.74. Track Nuvalent, Inc. stock price on the chart and check out the list of the most volatile stocks — is Nuvalent, Inc. there?
Today Nuvalent, Inc. has the market capitalization of ‪6.70 B‬, it has increased by 6.73% over the last week.
Yes, you can track Nuvalent, Inc. financials in yearly and quarterly reports right on TradingView.
Nuvalent, Inc. is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
NUVL earnings for the last quarter are −1.28 USD per share, whereas the estimation was −0.93 USD resulting in a −37.03% surprise. The estimated earnings for the next quarter are −1.07 USD per share. See more details about Nuvalent, Inc. earnings.
Nuvalent, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
NUVL net income for the last quarter is ‪−84.34 M‬ USD, while the quarter before that showed ‪−57.17 M‬ USD of net income which accounts for −47.54% change. Track more Nuvalent, Inc. financial stats to get the full picture.
No, NUVL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 3, 2024, the company has 92.00 employees. See our rating of the largest employees — is Nuvalent, Inc. on this list?
Like other stocks, NUVL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nuvalent, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nuvalent, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nuvalent, Inc. stock shows the buy signal. See more of Nuvalent, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.